These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33745422)

  • 1. The Emerging Landscapes to Drug Delivery Systems for the Treatment of Pancreatic Cancer.
    Magri A; Baveloni FG; de Camargo BAF; Chorilli M
    Curr Med Chem; 2021; 28(26):5411-5430. PubMed ID: 33745422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology.
    Zygmunt A; Gubernator J
    Expert Opin Drug Deliv; 2024 Jun; 21(6):845-865. PubMed ID: 38899424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix control of pancreatic cancer: New insights into fibronectin signaling.
    Topalovski M; Brekken RA
    Cancer Lett; 2016 Oct; 381(1):252-8. PubMed ID: 26742464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pancreas cancer microenvironment.
    Feig C; Gopinathan A; Neesse A; Chan DS; Cook N; Tuveson DA
    Clin Cancer Res; 2012 Aug; 18(16):4266-76. PubMed ID: 22896693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.
    Puleo F; Nicolle R; Blum Y; Cros J; Marisa L; Demetter P; Quertinmont E; Svrcek M; Elarouci N; Iovanna J; Franchimont D; Verset L; Galdon MG; Devière J; de Reyniès A; Laurent-Puig P; Van Laethem JL; Bachet JB; Maréchal R
    Gastroenterology; 2018 Dec; 155(6):1999-2013.e3. PubMed ID: 30165049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
    Huang H; Brekken RA
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organotypic slice cultures of pancreatic ductal adenocarcinoma preserve the tumor microenvironment and provide a platform for drug response.
    Lim CY; Chang JH; Lee WS; Lee KM; Yoon YC; Kim J; Park IY
    Pancreatology; 2018 Dec; 18(8):913-927. PubMed ID: 30292644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.
    Kajihara M; Takakura K; Kanai T; Ito Z; Matsumoto Y; Shimodaira S; Okamoto M; Ohkusa T; Koido S
    World J Gastroenterol; 2016 May; 22(18):4446-58. PubMed ID: 27182156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in drug delivery and targeting for the treatment of pancreatic cancer.
    Pramanik N; Gupta A; Ghanwatkar Y; Mahato RI
    J Control Release; 2024 Feb; 366():231-260. PubMed ID: 38171473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclopamine treatment disrupts extracellular matrix and alleviates solid stress to improve nanomedicine delivery for pancreatic cancer.
    Zhang B; Wang H; Jiang T; Jin K; Luo Z; Shi W; Mei H; Wang H; Hu Y; Pang Z; Jiang X
    J Drug Target; 2018 Dec; 26(10):913-919. PubMed ID: 29533111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
    Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.
    Rucki AA; Zheng L
    World J Gastroenterol; 2014 Mar; 20(9):2237-46. PubMed ID: 24605023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroma and pancreatic ductal adenocarcinoma: an interaction loop.
    Luo G; Long J; Zhang B; Liu C; Xu J; Ni Q; Yu X
    Biochim Biophys Acta; 2012 Aug; 1826(1):170-8. PubMed ID: 22521638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Contrast-enhanced MRI Detects Responses to Stroma-directed Therapy in Mouse Models of Pancreatic Ductal Adenocarcinoma.
    Cao J; Pickup S; Clendenin C; Blouw B; Choi H; Kang D; Rosen M; O'Dwyer PJ; Zhou R
    Clin Cancer Res; 2019 Apr; 25(7):2314-2322. PubMed ID: 30587546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical models of pancreatic ductal adenocarcinoma.
    Hwang CI; Boj SF; Clevers H; Tuveson DA
    J Pathol; 2016 Jan; 238(2):197-204. PubMed ID: 26419819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine in Pancreatic Cancer: A New Hope for Treatment.
    Redruello P; Perazzoli G; Cepero A; Quiñonero F; Mesas C; Doello K; Láinez-Ramos-Bossini A; Rivera-Izquierdo M; Melguizo C; Prados J
    Curr Drug Targets; 2020; 21(15):1580-1592. PubMed ID: 32619168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.
    Christenson ES; Jaffee E; Azad NS
    Lancet Oncol; 2020 Mar; 21(3):e135-e145. PubMed ID: 32135117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia: Friend or Foe for drug delivery in Pancreatic Cancer.
    Shah VM; Sheppard BC; Sears RC; Alani AW
    Cancer Lett; 2020 Nov; 492():63-70. PubMed ID: 32822815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology.
    Sielaff CM; Mousa SA
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1205-1217. PubMed ID: 29721665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Pancreatic Ductal Adenocarcinoma (PDAC).
    Parrasia S; Zoratti M; Szabò I; Biasutto L
    Cell Physiol Biochem; 2021 Jan; 55(1):61-90. PubMed ID: 33508184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.